Silexion Therapeutics Warrant
SLXNW
22 hedge funds and large institutions have $108K invested in Silexion Therapeutics Warrant in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
21.01% more ownership
Funds ownership: 23.82% → 44.83% (+21%)
12% less funds holding
Funds holding: 25 → 22 (-3)
46% less capital invested
Capital invested by funds: $199K → $108K (-$91.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.26K |
| 2 |
CS
Clear Street
New York
|
+$3.95K |
| 3 |
Goldman Sachs
New York
|
+$184 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$6.67K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$5.74K |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$1.15K |
| 4 |
Jane Street
New York
|
-$21 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
SLXNW Hedge Fund Activity: Q2 2025 in Review
22 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q2 2025, worth a combined $108K — down 46% from $199K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SLXNW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $5.26K. The largest seller was Periscope Capital, exiting entirely with an estimated $6.67K sold.
- 22 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q2 2025, down from 25 in Q1 2025.
- Funds reported $108K of Silexion Therapeutics Warrant stock for Q2 2025, down 46% quarter-over-quarter.
- 0 funds opened new Silexion Therapeutics Warrant positions in Q2 2025 and 3 closed out, a net change of -3 holders.
- The largest Silexion Therapeutics Warrant buyer in Q2 2025 was Susquehanna International Group, an estimated $5.26K added.
- The largest Silexion Therapeutics Warrant seller in Q2 2025 was Periscope Capital, an estimated $6.67K sold.
Based on aggregated 13F filings for Q2 2025.